| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2003.11.009 |
| P698 | PubMed publication ID | 14651956 |
| P50 | author | Hiroshi Seno | Q55510294 |
| Hiroaki Fukuzawa | Q92680259 | ||
| Tsutomu Chiba | Q113754504 | ||
| Shigeo Takaishi | Q116772104 | ||
| Mitsutaka Sawada | Q116772105 | ||
| Takahisa Kayahara | Q116772106 | ||
| Yukari Morita-Fujisawa | Q116772107 | ||
| P2093 | author name string | Katsumasa Suzuki | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 897-902 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Identification of GM-CSF in Paneth cells using single-cell RT-PCR | |
| P478 | volume | 312 |
| Q58126740 | A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease |
| Q35994058 | Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. |
| Q30436376 | Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice |
| Q64896435 | Attenuation of NF-κB in intestinal epithelial cells is sufficient to mitigate the bone loss co-morbidity of experimental mouse colitis. |
| Q64885862 | Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease. |
| Q34581819 | Crohn's disease: innate immunodeficiency? |
| Q39641148 | GM-CSF and GM-CSF receptor have regulatory role in transforming rat mesenteric mesothelial cells into macrophage-like cells. |
| Q36586289 | GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa |
| Q42616336 | GM-CSF: a role in immune and inflammatory reactions in the intestine |
| Q36045739 | Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis |
| Q34387000 | Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor. |
| Q50046087 | Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease |
| Q36802524 | Innovative therapeutics for inflammatory bowel disease |
| Q33694525 | Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing |
| Q34637765 | Intestine-specific ablation of mouse atonal homolog 1 (Math1) reveals a role in cellular homeostasis |
| Q30407940 | Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial |
| Q42843695 | Is Crohn's disease due to defective immunity? |
| Q34918999 | Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. |
| Q92078068 | Mist1 Expression Is Required for Paneth Cell Maturation |
| Q37051514 | Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage |
| Q26830824 | Pivotal roles of GM-CSF in autoimmunity and inflammation |
| Q37337711 | Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice |
| Q35161742 | Retinoic acid and GM-CSF coordinately induce retinal dehydrogenase 2 (RALDH2) expression through cooperation between the RAR/RXR complex and Sp1 in dendritic cells |
| Q36422338 | Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice |
| Q34660034 | STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation |
| Q48034825 | Sargramostim in patients with Crohn's disease: results of a phase 1-2 study |
| Q46191601 | Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways |
| Q43203199 | Treatment of Crohn's disease with colony-stimulating factors: An overview |
Search more.